nivolumab,etigilimab
mereo biopharmaceuticalceutical,bms,marker therapeutics
['etigilimab', 'biomarker', 'nivo', 'marker ', 'mereo ']
a great session presenting biomarker analysis of etig + nivo from the activate study at #esmo2022. we are encouraged by the totality of biomarker data which may provide a roadmap for future clinical studies of etigilimab. 
Mereo is a clinical-stage company focused on developing therapies in oncology & #orphandrugs / #rarediseasetherapies for #rarediseases